186 related articles for article (PubMed ID: 28687618)
21. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
Biochem Biophys Res Commun; 2014 Feb; 444(3):290-5. PubMed ID: 24342616
[TBL] [Abstract][Full Text] [Related]
22. Long Noncoding RNA LINC00092 Acts in Cancer-Associated Fibroblasts to Drive Glycolysis and Progression of Ovarian Cancer.
Zhao L; Ji G; Le X; Wang C; Xu L; Feng M; Zhang Y; Yang H; Xuan Y; Yang Y; Lei L; Yang Q; Lau WB; Lau B; Chen Y; Deng X; Yao S; Yi T; Zhao X; Wei Y; Zhou S
Cancer Res; 2017 Mar; 77(6):1369-1382. PubMed ID: 28087599
[TBL] [Abstract][Full Text] [Related]
23. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
24. Poly r(C) Binding Protein 1 Regulates Posttranscriptional Expression of the Ubiquitin Ligase TRIM56 in Ovarian Cancer.
Zhao L; Wang ZG; Zhang P; Yu XF; Su XJ
IUBMB Life; 2019 Feb; 71(2):177-182. PubMed ID: 30281912
[TBL] [Abstract][Full Text] [Related]
25. miR-100 antagonism triggers apoptosis by inhibiting ubiquitination-mediated p53 degradation.
Yang G; Gong Y; Wang Q; Wang L; Zhang X
Oncogene; 2017 Feb; 36(8):1023-1037. PubMed ID: 27524417
[TBL] [Abstract][Full Text] [Related]
26. The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
Shen J; Li P; Shao X; Yang Y; Liu X; Feng M; Yu Q; Hu R; Wang Z
Cancer Res; 2018 Jan; 78(2):359-371. PubMed ID: 29187402
[TBL] [Abstract][Full Text] [Related]
27. HUWE1 interacts with PCNA to alleviate replication stress.
Choe KN; Nicolae CM; Constantin D; Imamura Kawasawa Y; Delgado-Diaz MR; De S; Freire R; Smits VA; Moldovan GL
EMBO Rep; 2016 Jun; 17(6):874-86. PubMed ID: 27146073
[TBL] [Abstract][Full Text] [Related]
28. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARĪ± pathway in Chinese individuals.
Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W
Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064
[TBL] [Abstract][Full Text] [Related]
29. Long Intergenic Noncoding RNA
Takeiwa T; Mitobe Y; Ikeda K; Hasegawa K; Horie K; Inoue S
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681900
[TBL] [Abstract][Full Text] [Related]
30. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1.
Li D; Zhang Z
Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902
[TBL] [Abstract][Full Text] [Related]
31. CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.
Zhu W; Jarman KE; Lokman NA; Neubauer HA; Davies LT; Gliddon BL; Taing H; Moretti PAB; Oehler MK; Pitman MR; Pitson SM
Cancer Res; 2017 Sep; 77(18):4823-4834. PubMed ID: 28729416
[TBL] [Abstract][Full Text] [Related]
32. The structure and regulation of the E3 ubiquitin ligase HUWE1 and its biological functions in cancer.
Gong X; Du D; Deng Y; Zhou Y; Sun L; Yuan S
Invest New Drugs; 2020 Apr; 38(2):515-524. PubMed ID: 32008177
[TBL] [Abstract][Full Text] [Related]
33. HnRNPK/miR-223/FBXW7 feedback cascade promotes pancreatic cancer cell growth and invasion.
He D; Huang C; Zhou Q; Liu D; Xiong L; Xiang H; Ma G; Zhang Z
Oncotarget; 2017 Mar; 8(12):20165-20178. PubMed ID: 28423622
[TBL] [Abstract][Full Text] [Related]
34. Solenoid architecture of HUWE1 contributes to ligase activity and substrate recognition.
Hunkeler M; Jin CY; Ma MW; Monda JK; Overwijn D; Bennett EJ; Fischer ES
Mol Cell; 2021 Sep; 81(17):3468-3480.e7. PubMed ID: 34314700
[TBL] [Abstract][Full Text] [Related]
35. DNA damage-induced activation of CUL4B targets HUWE1 for proteasomal degradation.
Yi J; Lu G; Li L; Wang X; Cao L; Lin M; Zhang S; Shao G
Nucleic Acids Res; 2015 May; 43(9):4579-90. PubMed ID: 25883150
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of cullin-RING E3 ubiquitin ligase 4 with antitumor potential.
Wu K; Huynh KQ; Lu I; Moustakim M; Miao H; Yu C; Haeusgen MJ; Hopkins BD; Huang L; Zheng N; Sanchez R; DeVita RJ; Pan ZQ
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33602808
[TBL] [Abstract][Full Text] [Related]
37. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE
Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091
[TBL] [Abstract][Full Text] [Related]
38. SND1 facilitates the invasion and migration of cervical cancer cells by Smurf1-mediated degradation of FOXA2.
Zhan F; Zhong Y; Qin Y; Li L; Wu W; Yao M
Exp Cell Res; 2020 Mar; 388(1):111809. PubMed ID: 31891682
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
40. HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.
Wang X; Lu G; Li L; Yi J; Yan K; Wang Y; Zhu B; Kuang J; Lin M; Zhang S; Shao G
Biochem Biophys Res Commun; 2014 Feb; 444(4):549-54. PubMed ID: 24472556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
